First published · Last updated
Maintenance therapy in homologous recombination proficiency ovarian cancer: a clinical and economic challenge
A journal article published by Elsevier BV on 2025-10-01 examines maintenance therapy for ovarian cancer characterized by homologous recombination proficiency and describes it as a clinical and economic challenge. The source provided only the title, publisher, and publication date without further details.
Categories: public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 3/10
- Geographic reach
- 1/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 3/10
- Urgency
- 2/10
Why it matters
The article highlights clinical and economic issues for a specific ovarian cancer subgroup that may inform medical and policy discussions.

